Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.Journal of Neuro-Oncology|January 18, 2012
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathwayKe Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, et al.Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.Autophagy|February 9, 2008
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3Hiroshi Aoki, Yasuko Kondo, Kenneth Aldape, et al.Investigational New Drugs|July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiformeSusan M Chang, Patrick Wen, Timothy Cloughesy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant gliomaJohn G Kuhn, Susan M Chang, Patrick Y Wen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant GliomaFrederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.Pageof 2